Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

Back

ESC Professional Premium Access

Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

Session: Diagnostic accuracy of natriuretic peptides

Topic: Biomarkers

Speaker: Doctor Y. Takigami (Sagamihara, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Yu Takigami

Kitasato University School of Medicine, Sagamihara (Japan)

0 follower

8 more presentations in this session

ESC Heart Failure Association age-adjusted natriuretic peptide thresholds for a new diagnosis of heart failure: diagnostic accuracy study

Speaker: Professor C. Taylor (Birmingham, GB)

Screening for stage B heart failure in Type 2 diabetes: natriuretic peptide screening alone misses echocardiographic abnormalities

Speaker: Doctor C. Chandramouli (Singapore, SG)

Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy

Speaker: Doctor P. Gouda (Edmonton, CA)

Exploring heart failure prevalence and overlooked dimensions: a comprehensive NT Pro-BNP study in high-risk primary care patients

Speaker: Professor A. Celik (Mersin, TR)

Association of preoperative NT-proBNP with 30-day and five-year mortality after cardiac surgery

Speaker: Doctor F. Theurl (Innsbruck, AT)

Access the full session

Diagnostic accuracy of natriuretic peptides

Speakers: Doctor Y. Takigami, Professor C. Taylor, Doctor C. Chandramouli, Doctor P. Gouda, Professor A. Celik...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources